
BiostatisticsbiostsbiostsBiostatistics (Oxford, England)1465-46441468-4357Oxford University Press 10.1093/biostatistics/kxp027ArticlesEstimating dementia-free life expectancy for Parkinson's patients using Bayesian inference and microsimulation van den Hout Ardo *Matthews Fiona E. Medical Research Council Biostatistics Unit, Institute of Public Health, Robinson Way, Cambridge CB2 OSR, UK ardo.vandenhout@mrc-bsu.cam.ac.uk* To whom correspondence should be addressed.10 2009 31 7 2009 31 7 2009 10 4 729 743 11 9 2008 30 3 2009 12 5 2009 27 6 2009 Â© 2009 The Author(s)2009This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Interval-censored longitudinal data taken from a Norwegian study of individuals with Parkinson's disease are investigated with respect to the onset of dementia. Of interest are risk factors for dementia and the subdivision of total life expectancy (LE) into LE with and without dementia. To estimate LEs using extrapolation, a parametric continuous-time 3-state illnessâ€“death Markov model is presented in a Bayesian framework. The framework is well suited to allow for heterogeneity via random effects and to investigate additional computation using model parameters. In the estimation of LEs, microsimulation is used to take into account random effects. Intensities of moving between the states are allowed to change in a piecewise-constant fashion by linking them to age as a time-dependent covariate. Possible right censoring at the end of the follow-up can be incorporated. The model is applicable in many situations where individuals are followed over a long time period. In describing how a disease develops over time, the model can help to predict future need for health care.

DementiaLife expectancyMicrosimulationMultistate modelRandom effectsRight censoringSurvival
1. INTRODUCTION
Many population studies now have longitudinal follow-up and mortality information that can be combined to investigate transitions between health and ill health prior to death. Multistate models can be used to describe these transitions when states reflect health status and a death state is included. In describing how a disease develops over time, the models can help to predict future need for health care. Examples of applications are studies where patients are followed after a surgical operation, studies where stages of a disease are monitored after an infection, and longitudinal epidemiological studies. Our research was initiated by a Norwegian study into dementia and survival among patients with Parkinson's disease (Buter and others, 2008). In this study, the health states are â€œno dementia, dementia, and death,â€ with the assumption that transitions from dementia to no dementia are not possible. Individuals with Parkinson's disease are more likely to develop dementia than individuals without the disease (see, e.g. de Lau and others, 2005). For individuals with Parkinson's disease, the onset of dementia is an important predictor of health and need for care.

This paper presents Bayesian inference for a continuous-time 3-state illnessâ€“death Markov model. The intensities of moving between the states are related to covariates and random effects. By including age as a time-dependent covariate, time dependency of intensities can be taken into account in a piecewise-constant fashion. Relaxing the assumption of constant intensities makes the model applicable in many situations where individuals are followed over a long time period. One way to make use of the random-effect structure is to model possible heterogeneity that is not captured by observed covariates. The model in this paper assumes that transition times are interval censored except for known death times. Right censoring at the end of follow-up can be incorporated.

In addition, we show how to apply the Markov model to estimate life expectancy (LE). Using a parametric model for the time-dependent intensities makes it possible to extrapolate the model beyond the follow-up time and to estimate how many years of total LE will be spent in a disease state and which risk factors are important. In the presence of a random-effect structure, microsimulation can be used to estimate LE.

For the Norwegian study, Buter and others (2008) fitted a 3-state fixed-effect model using maximum likelihood estimation. They presented LEs conditional on baseline state and used a nonparametric bootstrap to estimate the variance of the estimated LEs. The Bayesian approach makes it easy to incorporate random effects, and there is no need for an additional stage for the estimation of the distribution of LEs because the approach is well suited to investigate derived variables from posterior distributions of the model parameters. In addition to the LEs conditional on baseline state, we estimate marginal LEs that do not require a specified baseline state but instead require the distribution of the baseline state.

One of the first publications on Bayesian inference for continuous-time multistate models is Sharples (1993). In recent years, additional work has been presented by, for example, Welton and Ades (2005) and Pan and others (2007). Our work can be seen as an extension to the Bayesian inference in Pan and others (2007) in that we allow for time-dependent intensities and exact death times.

Laditka and Wolf (1998) used microsimulation to estimate active LE given a fixed-effect discrete-time Markov model. The variance of estimated LE, however, was not discussed. To estimate the variance of quantities that are derived by using microsimulation, first- and second-order uncertainty have to be distinguished (Halpern and others, 2000). We will show how this is handled in our setting.

An important aspect of the data that determine the model chosen is whether or not transition times are known. For Bayesian inference given a multistate model with known transition times, see Kneib and Hennerfeind (2008). In our setting, as is common in many studies, known transition times are not available except for the transition into the death state. The disease status of the individuals is observed at prescheduled interviews, and as a consequence, observations are interval censored. Our multistate model is defined using transition intensities, but the likelihood contributions of observed time intervals are defined using transition probabilities. In this way, we account for the interval censoring in line with frequentist multistate models (see, e.g. Kay, 1986).

The paper is organized as follows. Section 2 introduces the model, and Section 3 shows how to estimate LEs given the model with random effects. In Section 4, an extension of the model is presented to take right censoring into account. Section 5 discusses the application, and Section 6 concludes the paper.

2. MARKOV MODEL
The first-order Markov assumption in a multistate model implies that the probability of moving to another state only depends on the current state. Our 3-state Markov model assumes that there is no recovery from State 2 back to State 1 and that known transition times are only available for transitions into the death state. We regress intensities on age as a time-dependent covariate to model possible change in the intensities.

In the model, the time interval between 2 consecutive measurements is not fixed but is allowed to vary between and within individuals. Although the model is formulated for individually observed time intervals, the subscript denoting individuals will be suppressed in order to keep notation simple. Let t denote time since entry to the study. At time t â‰¥ 0, the state of an individual is xt âˆˆ {1,2,3}. A transition at time t from State r to State s, r â‰  s, occurs with intensity qrs(t), where qrs(t) â‰¥ 0 for (r,s) âˆˆ {(1,2),(1,3),(2,3)} and qrs(t) = 0 for (r,s) âˆˆ {(2,1),(3,1),(3,2)}. Intensities are regressed on covariates and random effects by the log-linear model (2.1)  where vâŠ¤ denotes the transpose of vector v, Î²rs = (Î²0.rs,Î²1.rs,â€¦, Î²p.rs)âŠ¤, z(t) = (1,z1(t), â€¦, zp(t))âŠ¤, and random-effect parameter Ï„ = (Ï„12,Ï„13,Ï„23)âŠ¤ is multivariate normally distributed with mean zero and unknown covariance matrix Î£. The model is flexible to other random-effect structures as will be illustrated in the application.

The time dependency of the intensities is taken into account by a piecewise-constant approximation: intensities are assumed to be constant within individually observed time intervals but may vary between intervals. In our model, covariate vector z(t) is deterministic in the sense that we know its values at every time t â‰¥ 0. A typical example of this is the time-dependent covariate age. The constant intensities qrs(t) for an observed interval (t, u] are defined using the covariate values midway, that is, at time (t + u)/2. In case observed time intervals are wide and/or the time dependency is strong, this approach can be fine-tuned by subdividing observed intervals in shorter intervals and assuming that intensities are constant within the shorter intervals (Van den Hout and Matthews, 2008), but this method is not required here.

The statistical model is defined using transition probabilities, that is, probabilities of moving between the states. Transition probabilities for an observed time interval (t,u] are given by the 3Ã—3 matrix P(t, u) = exp[(u âˆ’ t)Q(t)], where for t â‰¥ 0 we define (2.2)  and where exp[M] is defined for any square matrix M as the limit of the series âˆ‘k = 0âˆMk/k!. The rs-entry P(t,u)[r,s] is given by â„™(Xu = s|Xt = r). See, for example, Norris (1997) for details on time-continuous Markov chains with constant intensities. Matrix P(t, u) is available in closed form for the 3-state model without recovery.

Assume that an individual has observations at times t1 = 0, t2,â€¦, tM. Using the Markov assumption, the probability of the observed trajectory xt1, xt2,â€¦, xtM conditional on the first observation xt1 is given by (2.3)  where the conditioning on covariates and random effects is ignored in the notation. The contribution of this individual to the marginal likelihood is given by (2.4)  where f is the density of the multivariate normal distribution with mean zero and covariance matrix Î£. To obtain the likelihood for the data, the individual contributions are taken together in a multiplication.

Given that the goal is Bayesian inference, we will use Markov chain Monte Carlo (MCMC) methods for approximating posterior distributions of model parameters. To do this, observed intervals (t1, t2],â€¦, (tM âˆ’ 1, tM] are modeled independently by using the multinomial distribution for the transitions to State Xj + 1 given State Xj, j = 1,â€¦,M âˆ’ 1 (Pan and others, 2007).

Assume that the individual with observation times t1 = 0,t2,â€¦,tM has random-effect parameter vector Ï„. We recode States 1, 2, and 3 as (1,0,0), (0,1,0), and (0,0,1), respectively. Accordingly, we change the notation for the random variable that denotes the state from scalar X to vector X. For intervals (tj, tj + 1] that an individual survives, we assume that  where (2.5)  for j âˆˆ {1, â€¦, M âˆ’ 1}.

In case an individual does not survive (tM âˆ’ 1,tM], we assume that  where (2.6)  given (2.7)  

This means that in case of death at tM, we assume an unknown state just before death and then a transition into the death state within a small time interval Ïµ (cf. Sharples, 1993). The probability of this event is denoted by Ï€d. Because of the Ïµ-approximation of the exact death time in (2.7), 1 âˆ’ Ï€d â‰  P(tM âˆ’ 1, tM)[xtM âˆ’ 1, 1] + P(tM âˆ’ 1, tM)[xtM âˆ’ 1, 2], hence the adjustment in (2.6) to ensure a proper distribution. Even though exact death times are known, we adhere to the Ïµ-approximation. In maximum likelihood estimation, instantaneous intensities can be used, and in that case, the likelihood contribution of an observed death time would be P(tM âˆ’ 1, tM)[xtM âˆ’ 1, 1]q13(t) + P(tM âˆ’ 1, tM)[xtM âˆ’ 1, 2]q23(t) (see, e.g. Van den Hout and Matthews, 2009). In the Bayesian framework, we have to ensure that Ï€d is a probability, that is, 0 â‰¤ Ï€d â‰¤ 1, and we use the Ïµ-approximation.

To estimate the total LE, the distribution of the state at baseline t1 = 0 is needed. At baseline, the state is either State 1 or State 2. We propose to use the logistic regression model for the distribution of X0 = Xt1. Defining Î¸ = â„™(X0 = 2|z(0)), this model is given by logit(Î¸) = Î±âŠ¤z(0), where Î± = (Î±1,â€¦,Î±p)âŠ¤. It follows that  

For ease of exposition, we use the same covariate vector for the baseline distribution and for the intensities. This is not a necessary condition.

The following priors are used for the model parameters in the application. For the regression coefficients in the model for baseline state and the regression coefficients in the Markov model, we specify vague univariate normal distributions with mean zero and large variance. For the inverse of covariance matrix Î£, we specify a Wishart distribution. These choices will be illustrated in Section 5.

With both the distribution of the data and the prior distribution of the parameters specified, MCMC methods can be used to estimate the model. The models in this paper were programmed and run in OpenBUGS (Thomas and others, 2006). Output of OpenBUGS can be transported into R (R Development Core Team, 2008) using the R package coda (Plummer and others, 2006).

3. LES AND MICROSIMULATION
For the case without random effects, LE in State s âˆˆ {1,2} given initial state r âˆˆ {1, 2} is given by (3.1)  where ğ’µ = {z(t)|t â‰¥ 0}. Expected LE in State s irrespective of the initial state (marginal LE) is given by (3.2)  where Î¸ = â„™(X0 = 2|ğ’µ) is as defined in Section 2. Expected total LE is given by etot(ğ’µ) = e1(ğ’µ) + e2(ğ’µ). For applications of LEs given frequentists illnessâ€“death Markov models, see, for example, Izmirlian and others (2000) and LiÃ¨vre and others (2003).

Two methods can be used to estimate the posterior distribution of LEs. The first approximates the integral in (3.1) numerically, for example, by using the trapezoidal rule. The second is microsimulation where individual trajectories are simulated and corresponding individual survival is used to estimate LEs. Both methods can be applied within each MCMC run or after convergence using the posterior distribution of the model parameters. Straightforward numerical evaluation is possible if the covariate vector z(t) is deterministic in the sense that conditional on z(0), ğ’µ is completely specified. Microsimulation is more flexible in that it can also deal with random effects and with time-dependent covariates such as information about visited states. Microsimulation has been used in evaluating screening interventions (Cronin and others, 1998) and in cost-effectiveness modeling (Spiegelhalter and Best, 2003).

3.1. Using the trapezoidal rule
For each simulated parameter vector of the Markov model, the trapezoidal rule is applied to estimate ers(ğ’µ). Using the simulated parameter vectors of the baseline distribution, we derive the posteriors of marginal LEs and total LE.

It make sense to use one time grid for both the trapezoidal rule and the piecewise-constant model. Given time grid u1 = 0,u2,â€¦, uM, we approximate integrand â„™(Xuj = s| X0 = r, ğ’µ) for all j âˆˆ {2,â€¦, M}. To take into account the time dependency of the intensities, we use a piecewise-constant iterative method given by (3.3)  

We use (0, uj) as an approximation for P(0, uj). Whereas in the estimation of the model we use individually observed time intervals for the piecewise-constant intensities, in the estimation of the LEs we impose a time grid.

3.2. Using microsimulation
Let the time grid be given by u1 = 0, u2,â€¦, uM with time between equal to 1 year. Given a simulated parameter vector of the Markov model, a large number of trajectories through the states are simulated conditional on baseline state. If there is a random-effect structure, then random effects are simulated for each trajectory. If simulated states are denoted by their number, then individual survival in State 1 is estimated by the number of 1s in the simulated trajectory plus half a year. The half-year correction is to take into account that a transition to a next state can take place at any time in the year. Individual survival in State 2 is estimated by the number of 2s. A finer grid is of course possible, but the counting of the states has to be adjusted to the grid.

More formally, the nested simulation procedure above is as follows. Let Ïˆ be the vector with the model parameters. First, values Ïˆb, b = 1,â€¦, B, are simulated from the posterior of Ïˆ. Second, conditional on Ïˆb, random effects Ï„bc, c = 1,â€¦, C, are simulated. Next conditional on Ïˆb and individual Ï„bc, a yearly trajectory is simulated and individual survival (generically denoted by Lbc) is calculated. Sample mean b and variance Vb are stored and are used to estimate first-order uncertainty ğ”¼Ïˆ[V[L|Ïˆ]] and second-order uncertainty VÏˆ[ğ”¼[L|Ïˆ]]. The former is the uncertainty caused by variability between individuals in the population, the latter is what we are after: uncertainty caused by model parameter uncertainty. The sum of these uncertainties is the total variance given by V[L] = ğ”¼Ïˆ[V[L|Ïˆ]] + VÏˆ[ğ”¼[L|Ïˆ]] (cf. Spiegelhalter and Best, 2003). In addition, we use the stored sample means to estimate ğ”¼[L] = ğ”¼Ïˆ[ğ”¼[L|Ïˆ]].

O'Hagan and others (2007) discuss the choice of the number of simulations in the nested procedure, that is, B for the first level and C for the second level, and present a method to reduce the computational burden in case one is only interested in the mean and the variance of L. In case the goal is the posterior distribution of L, C has to be large. In the application, we used the method of O'Hagan and others (2007) to check whether the chosen C was large enough.

4. RIGHT CENSORING
Often in longitudinal data there will be right censoring. If death during follow-up is always observed, right censoring in our model means that if the state at the end of the study time is not observed, we still know that the individual is alive.

To take right censoring into account, we extend the model in Section 2. First, states are denoted by X* and we code transition into the States 1, 2, 3, and the censored state by the vectors (1,0,0,0), (0,1,0,0), (0,0,1,0), and (0,0,0,1), respectively. The vectors are denoted by X*. The 3 Ã— 3 matrix P is computed as before. If the state at tM is neither death nor right censored, we assume that  where  for j = 1,â€¦, M âˆ’ 1. If the state at time tM is the death state or a censored state, we assume that  where, in case of death, we define Ï€M* = (Ï€M, 0) where Ï€M is obtained by (2.6) after replacing the xts by xt*s. In case of a censored state, we define Ï€M* = (0, 0, P(tM âˆ’ 1, tM)[xtM âˆ’ 1*, 3], 1 âˆ’ P(tM âˆ’ 1, tM)[xtM âˆ’ 1*, 3]). By specifying the contribution to the likelihood as 1 âˆ’ P(tM âˆ’ 1, tM)[xtM âˆ’ 1*, 3], that is, by the probability of not dying within time interval (tM âˆ’ 1, tM], we follow the literature on multistate model (see, e.g. Kay, 1986). Note that the contribution can be seen as P(Tâ€‰>â€‰C) when T is defined as time spent in the living states and C as the censoring time.

5. APPLICATION
5.1. Data
In a region with 220 000 inhabitants in Rogaland County, Norway, an attempt was made to recruit all individuals with recognized idiopathic Parkinson's disease. Parkinson's disease was diagnosed in 245 individuals. To avoid inclusion of individuals with dementia with Lewy bodies, 18 individuals with clinically significant cognitive impairment were excluded from the study. During follow-up, 3 individuals died before the first assessment, 7 were rediagnosed as not having Parkinson's disease, and 2 had schizophrenia, leaving n = 233 individuals eligible for the present study. The 233 individuals were followed from baseline 1993 up to 2005. For those individuals who did not die before 2005, interviews took place in 1993, 1997 and 2001â€“2005. There are 3 individuals with a censored last state. For further details, see Buter and others (2008).

In total, there were 897 observations (total number of interviews, censored states, and observed deaths), which means that there were 897 âˆ’ n = 664 observed intervals. The number of individuals who died during study time is 187. Individuals with only one interview are also included. In the latter case, observations consist of the initial state and a time of death or the initial state and the censored state at the end of follow-up. The mean length of observed time intervals in years is 2.48 (median 1.48), and the mean number of interviews is 3.03 (median 2).

Table 1 presents observed frequencies in each state at follow-up times. Because of the progressive nature of dementia, a missing state can sometimes be derived from consecutively observed states. For series of states 1?1, 2?2, and 2?3, where the question mark denotes a missing state, we know the missing state. There are 10 individuals with intermediate missing states that cannot be derived in this way. These missing states are noted in the table as the 6 + 5 + 4 + 4 + 3 = 22 censored states during follow-up. Missing intermediate states is not a problem for the estimation of the model but might bias results if the missingness is substantial. Our piecewise-constant model assumes that intensities are not changing between the interviews but might change from interview to interview. Missing several interviews affects the piecewise-constant approximation to the continuous time dependency of the intensities. Since there are only 10 persons with missing intermediate interviews and only 2 of them with more than 1 consecutive interview missing, we assume that the bias is negligible.

Table 1. Observed and rounded expected frequencies in each state at follow-up times in the Rogaland study, where (a + b) denotes a individuals previously in State 1 and b in State 2

State	Time in years	
	Baseline	4	8	9	10	11	12	
Observed	
â€ƒâ€ƒâ€ƒâ€ƒ1	171	86	42	38	31	29	24	
â€ƒâ€ƒâ€ƒâ€ƒ2	62	62(43â€‰+â€‰19)	54(25â€‰+â€‰29)	39(2â€‰+â€‰37)	28(2â€‰+â€‰26)	22(1â€‰+â€‰21)	19(5â€‰+â€‰14)	
â€ƒâ€ƒâ€ƒâ€ƒDead		79(36â€‰+â€‰43)	53(20â€‰+â€‰33)	20(3â€‰+â€‰17)	18(5â€‰+â€‰13)	9(2â€‰+â€‰7)	8(0â€‰+â€‰8)	
â€ƒâ€ƒâ€ƒâ€ƒCensored		6	5	4	4	3	3	
Expected given Model 1	
â€ƒâ€ƒâ€ƒâ€ƒ1	171	91	46	35	32	26	24	
â€ƒâ€ƒâ€ƒâ€ƒ2	62	66(42â€‰+â€‰22)	43(21â€‰+â€‰22)	47(5â€‰+â€‰42)	35(5â€‰+â€‰30)	26(4â€‰+â€‰22)	21(4â€‰+â€‰17)	
â€ƒâ€ƒâ€ƒâ€ƒDead		78(38â€‰+â€‰40)	59(19â€‰+â€‰40)	13(1â€‰+â€‰12)	8(1â€‰+â€‰9)	7(1â€‰+â€‰6)	6(1â€‰+â€‰5)	
Expected given Model 2	
â€ƒâ€ƒâ€ƒâ€ƒ1	171	87	49	37	33	27	25	
â€ƒâ€ƒâ€ƒâ€ƒ2	62	64(43â€‰+â€‰21)	44(19â€‰+â€‰25)	46(4â€‰+â€‰42)	35(4â€‰+â€‰31)	25(3â€‰+â€‰22)	21(3â€‰+â€‰18)	
â€ƒâ€ƒâ€ƒâ€ƒDead		83(41â€‰+â€‰41)	55(18â€‰+â€‰37)	13(1â€‰+â€‰12)	9(1â€‰+â€‰8)	7(1â€‰+â€‰6)	5(1â€‰+â€‰4)	
Frequencies of observed transitions between the states are given in Table 2. Note that there are no transitions from State 2 back to State 1. Three covariates will be used in the model: time-dependent age in years minus 77, sex as a dummy (0 â‰¡ men), and duration as the number of years the individual had Parkinson's disease before 1993 centered by subtracting 9 years. Before centering, minimum, mean, and maximum for age in years during follow-up are 36, 77.42, and 101, respectively. Minimum, mean, and maximum duration of Parkinson's disease in years are 1, 8.89, and 34, respectively. The time interval Ïµ that is used to approximate exact transition times into the death state is fixed to be Ïµ = 0.001 years. This value was chosen because it is small, and there is no individual in the data who dies within 0.001 years of their last interview.

Table 2. Frequencies of observed transitions between the states in the Rogaland study

		To state	Death	Censored	
		1	2			
From state	1	250	78	66	3	
	2	0	146	121	0	
5.2. Models
Using t as the number of years since baseline, we specify 2 models. The models are the results of a model comparison that can be found in Section A of the supplementary material available at Biostatistics online. Fixed-effect Model 1 encompasses a model for the baseline state and one for the intensities and is given for individual i by  

Model 2 has the same model for the baseline and the same restrictions for the fixed effects. The model for the intensities, however, is extended with random effects and is given by  

Model 2 for the intensities is a slightly extended version of model (2.1). We include the random slope Î³ai to allow Ï„rsi(t) to change over time.

For the fixed-effect regression coefficients in Models 1 and 2, we specified vague univariate normal distributions with mean zero and variance equal to 1000. For Model 2, a prior is needed for 4 Ã— 4 covariance matrix Î£. Here we followed common practice and used a Wishart distribution to specify the prior of the precision matrix T = Î£ âˆ’ 1, that is, T âˆ¼ W(R âˆ’ 1,4), where R is a 4 Ã— 4 matrix. Since ğ”¼[T] = 4R âˆ’ 1, it follows that 4 âˆ’ 1R can be seen as a prior guess at the order of magnitude of Î£.

Given a model, MCMC consisted of 2 chains with different starting values for Î±, Î²12, Î²13, and Î²23. For both chains, the first 50 000 iterations were ignored (burn-in) and the additional 50 000 iterations were thinned and used to compute the posterior means, the 95% credible intervals, and the deviance information criterion (DIC, Spiegelhalter and others, 2002). For the models in this paper, the MCMC took about 2 h to run on a 2.59-GHz PC with dual core AMD microprocessor. Convergence of the chain was checked visually by plotting the chains, the autocorrelation, and the Gelmanâ€“Rubin convergence statistic, as modified by Brooks and Gelman (1998). Numerically, convergence was assessed by checking the Monte Carlo error. All these functions can be called within OpenBUGS. We used the DIC to compare models. The DIC comparison is based on trade-off between the fit of the data to the model and the complexity of the model. Models with smaller DIC are better supported by the data.

Both Models 1 and 2 have DICâ€‰=â€‰4142. It makes sense in this case to choose Model 1 as it is the most parsimonious. However, we think that Model 2 is interesting as it includes random effects to capture possible heterogeneity not captured by the covariates and it allows random effects to change over time by regressing the effects on time-dependent age. To estimate LEs, we have to extrapolate the model beyond the follow-up of the survey. Assuming no heterogeneity beyond the covariates and no further change over time beyond the fixed effect of age might be too restrictive.

A sensitivity analysis with regard to the specification of priors was conducted. For the fixed effects, alternative univariate normal distributions were investigated with mean zero and variance equal to either 100 or 10000. For Model 2, alternative priors for the precision matrix T were considered. Denote the diagonal entries of R for the random intercepts r1 and the diagonal entries for the random slopes r2. The DICs varied slightly for specifications (r1,r2) = (1,0.001), (r1,r2) = (2,0.01), and (r1,r2) = (0.25,0.001), but we do not consider the variation to be significant. (For details, see Section B of the supplementary material available at Biostatistics online.)

5.3. Inference
Table 3 presents posterior means for the parameters in Models 1 and 2. For Model 2, we provide posterior means of Ïƒ0.12 = Î£111/2, Ïƒ0.13 = Î£221/2, Ïƒ0.23 = Î£331/2, and Ïƒa = Î£441/2. There are differences in the posterior means of the covariate effects. Note that for Model 2, the means for the covariate effects are all larger than for Model 1. These differences and the posterior means of standard deviations of Ïƒ0.12,Ïƒ0.12,Ïƒ0.23, and Ïƒa show that adding the random effects lead to a different description of the data.

Table 3. Posterior means and DICs for Models 1 and 2 each including a Markov model and a logistic regression model for the baseline; 95% credible intervals in parentheses

		Model 1	Model 2	
Markov model	
â€ƒâ€ƒâ€ƒâ€ƒIntercepts	Î²0.12	â€“ 1.496(â€“ 1.795, â€“ 1.221)	â€“ 1.394(â€“ 1.772, â€“ 1.015)	
	Î²0.13	â€“ 4.013(â€“ 5.127, â€“ 3.271)	â€“ 4.342(â€“ 5.716, â€“ 3.420)	
	Î²0.23	â€“ 1.286(â€“ 1.533, â€“ 1.053)	â€“ 1.288(â€“ 1.574, â€“ 1.009)	
â€ƒâ€ƒâ€ƒâ€ƒAge	Î²a.12	0.086(0.057, 0.115)	0.105(0.066, 0.152)	
	Î²a.13	0.050(â€“ 0.028, 0.147)	0.057(â€“ 0.035, 0.167)	
	Î²a.23	0.027(0.005, 0.054)	0.043(0.010, 0.079)	
â€ƒâ€ƒâ€ƒâ€ƒSex	Î²s.12	â€“ 0.571(â€“ 0.970, â€“ 0.174)	â€“ 0.590(â€“ 1.098, â€“ 0.091)	
	Î²s.13	0â€ 	0â€ 	
	Î²s.23	â€“ 0.361(â€“ 0.682, â€“ 0.038)	â€“ 0.427(â€“ 0.809, â€“ 0.059)	
â€ƒâ€ƒâ€ƒâ€ƒDuration	Î²d.12	0.069 (0.027, 0.111)	0.080 (0.029, 0.136)	
	Î²d.13	0â€ 	0â€ 	
	Î²d.23	0â€ 	0â€ 	
â€ƒâ€ƒâ€ƒâ€ƒRandom effect	Ïƒ0.12		0.650 (0.350, 1.111)	
	Ïƒ0.13		0.748 (0.349, 1.583)	
	Ïƒ0.23		0.436 (0.280, 0.653)	
	Ïƒa		0.047 (0.030, 0.071)	
Logistic regression model		
â€ƒâ€ƒâ€ƒâ€ƒIntercept	Î±0	â€“ 0.914(â€“ 1.255, â€“ 0.584)	â€“ 0.912(â€“ 1.261, â€“ 0.581)	
â€ƒâ€ƒâ€ƒâ€ƒAge	Î±a	0.166(0.112, 0.224)	0.165(0.112, 0.225)	
â€ƒâ€ƒâ€ƒâ€ƒSex	Î±s	0â€ 	0â€ 	
â€ƒâ€ƒâ€ƒâ€ƒDuration	Î±d	0.047(â€“ 0.009, 0.104)	0.047(â€“ 0.008, 0.103)	
â€  Restricted to zero.

Both models show that for individuals with Parkinson's disease but without dementia, sex and the duration of the disease at baseline do not have an effect on the intensities for transitions to the death state. Further restriction, Î²d.23 = 0 indicates that for individuals with Parkinson's disease and dementia, the history of the disease at baseline does not have an effect on the transition to the death state. The unrestricted regression coefficients show that all covariates are important for the onset of dementia and that given Parkinson's disease men are more likely to become demented than women of the same age and with the same history of the disease at baseline. Posterior means for the logistic regression model for the baseline state probability Î¸ = â„™(X0 = 2|z(0)) show that with increasing age and more years of duration, it is more likely that the patient is demented. This concurs with our expectations.

The computation of the LEs was done using the posterior of the model parameters derived from MCMC after the burn-in. The time between h in the time grid for the LEs was 1 year. Table 4 presents the results. For Model 1 without random effects, we used both microsimulation and the trapezoidal rule in order to compare performance. For Model 2, we used microsimulation. To approximate LE given by (3.1), we impose a time that represents infinity conditional on specified age at baseline. This time is the time to assumed maximum age minus age at baseline. For maximum age, we choose 110 years old, whichâ€”for Parkinson's disease patientsâ€”seems reasonable. Microsimulation is computationally intensive. For B = C = 1000, the simulation took twice the time taken to estimate the model via MCMC. The estimation seems to be robust regarding the specification of the time between in the time grid. For h equal to 1/2 year, the results (not shown) are very similar.

Table 4. Posterior means for LEs for men with 8 years of Parkinson's disease at baseline. Estimation for Models 1 and 2 with 95% credible intervals in parentheses

	Model 1	Model 2	
	Trapezoidal rule (Bâ€‰=â€‰1000)	Microsimulation (Bâ€‰=â€‰Câ€‰=â€‰1000)	Microsimulation (Bâ€‰=â€‰Câ€‰=â€‰1000)	
Age 60 years				
â€ƒâ€ƒâ€ƒâ€ƒe11	8.7 (7.1, 10.4)	8.8 (7.0, 10.5)	9.4 (7.5, 11.5)	
â€ƒâ€ƒâ€ƒâ€ƒe12	3.5 (2.6, 4.5)	3.5 (2.6, 4.6)	3.7 (2.7, 5.0)	
â€ƒâ€ƒâ€ƒâ€ƒe22	5.0 (3.1, 7.0)	5.0 (3.1, 7.2)	6.3 (4.0, 8.7)	
â€ƒâ€ƒâ€ƒâ€ƒe1	8.5 (6.9, 10.1)	8.5 (6.8, 10.3)	9.2 (7.3, 11.3)	
â€ƒâ€ƒâ€ƒâ€ƒe2	3.6 (2.7, 4.6)	3.6 (2.6, 4.6)	3.8 (2.7, 5.0)	
â€ƒâ€ƒâ€ƒâ€ƒetot	12.0 (10.3, 13.8)	12.1 (10.2, 14.0)	13.0 (10.9, 15.1)	
Age 70 years				
â€ƒâ€ƒâ€ƒâ€ƒe11	5.0 (4.1, 5.9)	5.0 (4.1, 6.0)	5.3 (4.2, 6.6)	
â€ƒâ€ƒâ€ƒâ€ƒe12	3.1 (2.5, 3.8)	3.1 (2.5, 3.9)	3.3 (2.5, 4.2)	
â€ƒâ€ƒâ€ƒâ€ƒe22	3.9 (3.0, 4.8)	3.9 (3.0, 4.9)	4.3 (3.2, 5.6)	
â€ƒâ€ƒâ€ƒâ€ƒe1	4.4 (3.6, 5.3)	4.4 (3.7, 5.4)	4.7 (3.7, 5.9)	
â€ƒâ€ƒâ€ƒâ€ƒe2	3.2 (2.6, 3.9)	3.2 (2.5, 4.0)	3.4 (2.6, 4.4)	
â€ƒâ€ƒâ€ƒâ€ƒetot	7.6 (6.7, 8.6)	7.7 (6.7, 8.7)	8.1 (6.9, 9.4)	
Using the 1-way analysis of variance technique proposed by O'Hagan and others (2007), we checked results by comparing estimated standard errors. For C = 1000, there is indeed some consistent overestimation, but the bias is negligible for practical purposes. (For details, see Section C of the supplementary material available at Biostatistics online.)

For Model 1, the posterior densities of the LEs for men aged 60 years at baseline with 8 years of Parkinson's disease at baseline are given in Figure 1. The dashed lines are the expectancies computed using the trapezoidal rule, and the solid lines are the expectancies computed using microsimulation. The results for the trapezoidal rule are a bit smoother. Overall, however, differences are minimal.

Fig. 1. For Model 1, posterior distributions of the LEs for men aged 60 years at baseline with 8 years of Parkinson's disease at baseline (solid lines for microsimulation; dashed lines for trapezoidal rule).

For Model 2, credible intervals are wider. This is to be expected as there will be more variation due to the random effects. Posterior means for LEs for Model 2 are higher than the means for Model 1, especially for e11 and e1. This is not due to skewed distributions for Model 2. Median LEs (not shown) are very similar to the means reported in Table 4. Note that given a specific age at baseline, zero is the lower bound for the simulated LE, but there is no upper bound other than the assumed maximum age. The higher LEs for Model 2 are caused by simulated random effects that reflect more healthy individuals with relatively long lives. This trend may reflect the data where there is less information for the more healthy individuals who stay in State 1 during the whole follow-up.

Even though the 2 models yield different estimates, the differences are within bounds. Looking at the results for Models 1 and 2 for the LEs, it is interesting to note that the years spent with dementia irrespective of baseline state (e2) do not differ much for the ages 60 and 70. Given that the extrapolation is largest for those aged 60 years, it is understandable that the 95% credible intervals are wider for those aged 60 years than for those aged 70 years.

5.4. Validation
Given the regular observation times in the Rogaland study, we can investigate some aspects of goodness of fit by comparing observed frequencies in each state with expected frequencies. The approach is inspired by the model assessment in the R package for multistate models msm (Jackson and others, 2003) but differs from msm in that it works with the observed covariate values at baseline. In principle, the setup makes it possible to use the Bayesian Ï‡2 test for goodness-of-fit as introduced by Johnson (2004). However, this Ï‡2 test relies on asymptotic properties that are not met in our situation. (For details see Section D of the supplementary material available at Biostatistics online.)

Observation times other than death take place at years t0, t1,â€¦, t6 = 0, 4, 8, 9, 10, 12. Let n denote the number of individuals in the data and let Xti denote the state of individual i at time t. For State s âˆˆ {1, 2, censored}, define observed frequencies O[s, tj] = âˆ‘i = 1n1{Xtji = s}, for j = 2,â€¦, 6. Given the known death times, we define O[dead,tj] = âˆ‘i = 1n1{âˆƒt*[tj âˆ’ 1 < t*â€‰<â€‰tj âˆ§ Xt*i = dead]}, for j = 2,â€¦, 6. These frequencies are presented in Table 1. The table also shows the observed frequencies split according to the previously observed state. For example, 4 years after baseline, from the 62 individuals who are observed in State 2, 43 were observed in State 1 at baseline and 19 were observed in State 2 at baseline.

Observed frequencies can be compared with expected frequencies by defining table E[t] = âˆ‘i = 1nPi(t, 0), where Pi(t, 0) is the matrix with the transition probabilities for individual i derived from a simulated model parameter vector (for Model 2, this includes the random effects). The individual transition matrices are approximated using the grid approach in (3.3), where the grid is given by t0,t1,â€¦, t6. In this approximation, the covariate values of individual i at baseline are used and the change of age at the grid points is taken into account.

For a visual inspection of goodness of fit, 1000 simulated values of the parameter vectors are used to computed 1000 times E[t]. For Models 1 and 2, the mean of the 1000 simulated tables is presented in Table 1 as the expected frequencies. In general, observed and expected frequencies are similar for both models. There is a deviation for State 2 in the later years in the sense that the number of individuals in State 2 is overestimated and the number of deaths underestimated. Although this is not a proper statistical test, Table 1 shows that Models 1 and 2 fit the data reasonably well.

6. DISCUSSION
LEs in health and ill health can be of importance for the planning of future health care. Survival is not only about total LE but also about whether or not remaining life time will be spent in good health. For longitudinal data, we have shown how transitions between health, ill health, and death can be modeled using the Bayesian framework. In addition, we have shown how to estimate the posterior densities of LEs in health and ill health. In many longitudinal studies, transition intensities will change over time and one way of taking this into account is to include age as a time-dependent covariate for the intensities.

The approach is illustrated using a 3-state model without recovery for Parkinson's patients where dementia represents ill health. BUGS was used for estimation with MCMC. The model in the paper can be extended to more complex models, for instance models with recovery from the ill health state or model with more states. When there is a closed-form expression for the matrix with the transition probabilities given the transition intensities, the standard functions in BUGS can be used to estimate the model. Another possibility is to disentangle the effect of baseline age and the effect of time by using qrs(t) = exp[Î²0.rs + Î²t.rst + Î²a.rs A g e(0) + â‹¯], where Age(0) is age at the start of the study.

Interval censoring is an important feature of the data that we analyzed. If exact transition times had been available for transitions out of State 1, standard survival models might have been applied to estimate LE in State 1. The problem for an observed series of states such as 1113 is that we do not know whether the latent trajectory was via State 2 or directly from State 1 to State 3. We could right censor the series midway the last time interval as an approximation, but this leads to 100% censoring. For LE in State 2, standard survival models be sufficient, but it will only address part of our research question. Applying a multistate model seems to be best option as it formulates an overall model and makes it possible to borrow strength across the transitions, for example, via shared random effects such as the random slopes in the application.

The first-order Markov assumption that is often used in applications of multistate models is not always realistic. The model for the Parkinson's disease study uses the Markov assumption, and the informal assessment of goodness of fit shows that the model fits the data well. The use of age as a time-dependent covariate is crucial here. For example, time spent in the dementia state might have an effect on the risk of moving to the death state, but part of this is covered by the effect of changing age.

We have illustrated the use of microsimulation in the estimation of LEs when the regression model for the intensities includes random effects. Direct numerical approximation of the complex multidimensional integral that takes into account random effects and time-dependent age may often not be feasible. Microsimulation is an alternative that is intuitive and easy to implement. We think that microsimulation has potential for more complex multistate models. To estimate LEs, the multistate model is extrapolated beyond the follow-up of the study and this asks for special methods in case covariates are not deterministic. For example, given a 3-state illnessâ€“death model with recovery, it is possible to add the covariate â€œpreviously observed in State 2â€. This covariate is not deterministic but can be used in a microsimulation where individual trajectories are simulated and the next state is simulated conditional on the history of previously simulated states.

FUNDING
Funding to pay the Open Access publication charges for this article was provided by the UK Medical Research Council Biostatistics Unit (U.1052.00.013).

SUPPLEMENTARY MATERIAL
Supplementary Material is available at http://www.biostatistics.oxfordjournals.org.

[Supplementary Material]
 The authors would like to thank 2 anonymous referees for comments that helped to improve the manuscript. The Parkinson's disease data are kindly provided by the Norwegian Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway. Conflict of Interest: None Declared.
Brooks S  Gelman A   Alternative methods for monitoring convergence of iterative simulations Journal of Computational and Graphical Statistics 1998 7 434 455 
Buter TC  Van den Hout A  Matthews FE  Larsen JP  Brayne C  Aarsland D   Dementia and survival in Parkinson's diseaseâ€”a twelve year population study Neurology 2008 70 1017 1022 18362281 
Cronin KA  Legler JM  Etzioni RD   Assessing uncertainty in microsimulation modelling with application to cancer screening interventions Statistics in Medicine 1998 17 2509 2523 9819842 
de Lau LML  Schipper CMA  Hofman A  Koudstaal PJ  Breteler MMB   Prognosis of Parkinson disease: risk of dementia and mortality: the Rotterdam study Archives of Neurology 2005 62 1265 1269 16087767 
Halpern EF  Weinstein MC  Hunink MGM  Gazelle GS   Representing both first- and second-order uncertainties by Monte Carlo simulation for groups of patients Medical Decision Making 2000 20 314 322 10929854 
Izmirlian G  Brock D  Ferrucci L  Phillips C   Active life expectancy from annual follow-up data with missing responses Biometrics 2000 56 244 248 10783802 
Jackson CH  Sharples LD  Thompson SG  Duffy SW  Couto E   Multi-state Markov models for disease progression with classification error Statistician 2003 52 193 209 
Johnson VE   A Bayesian Ï‡ 2  test for goodness-of-fit The Annals of Statistics 2004 32 2361 2384 
Kay R   A Markov model for analysing cancer markers and disease states in survival studies Biometrics 1986 42 855 865 2434150 
Kneib T  Hennerfeind A   Bayesian semi parametric multi-state models Statistical Modelling 2008 8 169 198 
Laditka SB  Wolf AW   New methods for analyzing active life expectancy Journal of Aging and Health 1998 10 214 241 
LiÃ¨vre A  Brouard N  Heathcote C   The estimation of health expectancies from cross-longitudinal surveys Mathematical Population Studies 2003 10 211 248 
Norris JR   Markov Chains 1997 Cambridge Cambridge University Press 
O'Hagan A  Stevenson M  Madan J   Monte Carlo probabilistic sensitivity analysis for patient level simulation models: efficient estimation of mean and variance using ANOVA Health Economics 2007 16 1009 1023 17173339 
Pan SL  Wu HM  Yen AMF  Chen THH   A Markov regression random-effects model for remission of functional disability in patients following a first stroke: a Bayesian approach Statistics in Medicine 2007 26 5335 5353 17676712 
Plummer M  Best N  Cowles K  Vines K   CODA: convergence diagnosis and output analysis for MCMC R News 2006 6 7 11 
R Development Core Team   R: A Language and Environment for Statistical Computing R Foundation for Statistical Computing 2008 Vienna Austria 
Salazar JC  Schmitt FA  Yu L  Mendiondo MM  Kryscio RJ   Shared random effects analysis of multi-state Markov models: application to a longitudinal study of transitions to dementia Statistics in Medicine 2007 26 568 580 16345024 
Sharples LD   Use of the Gibbs sampler to estimate transition rates between grades of coronary disease following cardiac transplantation Statistics in Medicine 1993 12 1155 1169 8210819 
Spiegelhalter DJ  Abrams KR  Myles JP   Bayesian Approaches to Clinical Trials and Health-Care Evaluation 2004 Chichester, UK Wiley 
Spiegelhalter DJ  Best NG   Bayesian approaches to multiple sources of evidence and uncertainty in complex cost-effectiveness modelling Statistics in Medicine 2003 22 3687 3709 14652869 
Spiegelhalter DJ  Best NG  Carlin BP  Van der Linde A   Bayesian measures of model complexity and fit (with discussion) Journal of the Royal Statistical Society, Series B 2002 64 583 640 
Thomas A  O'Hara B  Ligges U  Sturtz S   Making BUGS open R News 2006 6 12 17 
Van den Hout A  Matthews FE   A piecewise-constant Markov model and the effects of study design on the estimation of life expectancies in health and ill health Statistical Methods in Medical Research 2008 18 145 162 18445698 
Welton NJ  Ades AD   Estimation of Markov chain transition probabilities and rates from fully and partially observed data: uncertainty propagation, evidence synthesis, and model calibration Medical Decision Making 2005 25 633 645 16282214
